Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an announcement.
Lifecare ASA has completed the exercise of 107,059,776 Series 1 warrants at an exercise price of NOK 0.3342 per share, raising gross proceeds of NOK 35.8 million. Following registration of the related share capital increase, the company’s share capital now stands at NOK 29,812,074.90 divided into 298,120,749 shares, and the new shares are expected to be delivered to investors’ VPS accounts around 26 March 2026.
The successful warrant exercise strengthens Lifecare’s capital base after its partially underwritten rights issue earlier in the year. This additional funding is expected to support the company’s development and commercialization efforts in continuous glucose monitoring and broader medical sensor applications, reinforcing its positioning within the medical technology sector.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes. The company is primarily working on next-generation continuous glucose monitoring systems based on osmotic pressure sensing, with applications for both humans and pets.
Average Trading Volume: 5,026,733
Current Market Cap: NOK78.72M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.